share_log

和黃醫藥:自願性公告 - 和黃醫藥將於2022年ESMO年會上公佈Fruquintinib國際多中心臨床試驗FRESCO-2的研究數據

HUTCHMED: VOLUNTARY ANNOUNCEMENT - HUTCHMED Highlights Fruquintinib MRCT FRESCO-2 Data to be Presented at the Upcoming ESMO Congress 2022

Aug 23, 2022 04:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more